Kiniksa Pharmaceuticals International (KNSA) EBITDA Margin (QoQ) (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.43 Bn | 43.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.65 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.09 Bn | 19.43 Bn | 683.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.12 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.04 Bn | 11.51 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.16 Bn | 5.63 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -250.00 |
| Mar 31, 2026 | 388.00 |
| Dec 31, 2025 | -350.00 |
| Sep 30, 2025 | 42.00 |
| Jun 30, 2025 | 322.00 |
| Mar 31, 2025 | 2,538.00 |
| Dec 31, 2024 | -714.00 |
| Sep 30, 2024 | -850.00 |
| Jun 30, 2024 | 2,061.00 |
| Mar 31, 2024 | -2,081.00 |
| Dec 31, 2023 | 1,639.00 |
| Sep 30, 2023 | -1,188.00 |
| Jun 30, 2023 | 1,875.00 |
| Mar 31, 2023 | -1,908.00 |
| Dec 31, 2022 | -5,090.00 |
| Sep 30, 2022 | 11,863.00 |
| Jun 30, 2022 | 64.00 |
| Mar 31, 2022 | 12,031.00 |
| Dec 31, 2021 | 6,080.00 |
| Sep 30, 2021 | 27,286.00 |